SG11202103884UA - Methods for sample quality assessment - Google Patents

Methods for sample quality assessment

Info

Publication number
SG11202103884UA
SG11202103884UA SG11202103884UA SG11202103884UA SG11202103884UA SG 11202103884U A SG11202103884U A SG 11202103884UA SG 11202103884U A SG11202103884U A SG 11202103884UA SG 11202103884U A SG11202103884U A SG 11202103884UA SG 11202103884U A SG11202103884U A SG 11202103884UA
Authority
SG
Singapore
Prior art keywords
methods
quality assessment
sample quality
sample
assessment
Prior art date
Application number
SG11202103884UA
Other languages
English (en)
Inventor
Dominic Zichi
Matthew Westacott
Original Assignee
Somalogic Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Somalogic Inc filed Critical Somalogic Inc
Publication of SG11202103884UA publication Critical patent/SG11202103884UA/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/544Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being organic
    • G01N33/548Carbohydrates, e.g. dextran
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803General methods of protein analysis not limited to specific proteins or families of proteins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/10Type of nucleic acid
    • C12N2310/16Aptamers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2525/00Reactions involving modified oligonucleotides, nucleic acids, or nucleotides
    • C12Q2525/10Modifications characterised by
    • C12Q2525/205Aptamer

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Peptides Or Proteins (AREA)
SG11202103884UA 2018-10-30 2019-10-28 Methods for sample quality assessment SG11202103884UA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862752947P 2018-10-30 2018-10-30
PCT/US2019/058302 WO2020092211A1 (en) 2018-10-30 2019-10-28 Methods for sample quality assessment

Publications (1)

Publication Number Publication Date
SG11202103884UA true SG11202103884UA (en) 2021-05-28

Family

ID=70464670

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202103884UA SG11202103884UA (en) 2018-10-30 2019-10-28 Methods for sample quality assessment

Country Status (10)

Country Link
US (1) US20210311071A1 (ko)
EP (1) EP3874043A4 (ko)
JP (1) JP7467447B2 (ko)
KR (1) KR20210089178A (ko)
CN (1) CN113167782A (ko)
AU (1) AU2019371238A1 (ko)
CA (1) CA3116768A1 (ko)
IL (1) IL282501A (ko)
SG (1) SG11202103884UA (ko)
WO (1) WO2020092211A1 (ko)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2023210219A1 (en) * 2022-01-21 2024-06-13 Somalogic Operating Co., Inc. Methods for sample quality assessment
CN114739977A (zh) * 2022-04-13 2022-07-12 重庆大学 基于随机森林法的油纸绝缘老化光谱特征提取方法及系统
WO2023211771A1 (en) * 2022-04-24 2023-11-02 Somalogic Operating Co., Inc. Methods for sample quality assessment
WO2023211769A1 (en) * 2022-04-24 2023-11-02 Somalogic Operating Co., Inc. Methods for sample quality assessment
WO2023211770A1 (en) * 2022-04-24 2023-11-02 Somalogic Operating Co., Inc. Methods for sample quality assessment
WO2023211773A1 (en) * 2022-04-24 2023-11-02 Somalogic Operating Co., Inc. Methods for sample quality assessment
WO2024015486A1 (en) * 2022-07-14 2024-01-18 Somalogic Operating Co., Inc. Methods for sample quality assessment

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2439854A1 (en) * 2001-03-01 2002-09-12 Epigenomics Ag Method for the development of gene panels for diagnostic and therapeutic purposes based on the expression and methylatoin status of the genes
BRPI0411526A (pt) * 2003-06-18 2006-08-01 Genelux Corp vìrus de vaccinia e outros microrganismos recombinates modificados e usos dos mesmos
CN102089654A (zh) * 2008-03-10 2011-06-08 莱恩进公司 Copd生物标志标签
EP2591357A4 (en) * 2010-07-09 2014-01-01 Somalogic Inc BIOMARKER FOR LUNG CANCER AND USE
WO2012170669A1 (en) 2011-06-07 2012-12-13 Yale University Avenue Biomarkers for assessment of the molecular quality in biospecimens
US20130103321A1 (en) * 2011-10-24 2013-04-25 Somalogic, Inc. Selection of Preferred Sample Handling and Processing Protocol for Identification of Disease Biomarkers and Sample Quality Assessment
WO2016069461A1 (en) 2014-10-27 2016-05-06 The Trustees Of The University Of Pennsylvania A parkinson's disease diagnostic biomarker panel
WO2017044715A1 (en) * 2015-09-09 2017-03-16 Somalogic, Inc. Methods for developing personalized drug treatment plans and targeted drug development based on proteomic profiles
CN108369612A (zh) 2015-11-04 2018-08-03 梅塔博隆股份有限公司 自动化样品质量评估

Also Published As

Publication number Publication date
KR20210089178A (ko) 2021-07-15
WO2020092211A1 (en) 2020-05-07
AU2019371238A1 (en) 2021-06-03
CA3116768A1 (en) 2020-05-07
CN113167782A (zh) 2021-07-23
IL282501A (en) 2021-06-30
JP2022512890A (ja) 2022-02-07
JP7467447B2 (ja) 2024-04-15
EP3874043A4 (en) 2022-10-26
EP3874043A1 (en) 2021-09-08
US20210311071A1 (en) 2021-10-07

Similar Documents

Publication Publication Date Title
IL277715A (en) Characteristic of optical samples
IL282501A (en) Methods for assessing sample quality
HU4811U (hu) Berendezés kézfertõtlenítés minõségének ellenõrzésére
GB201706572D0 (en) Methods for colorimetric analysis
SG10201911114RA (en) Test apparatus
EP3321866A4 (en) Method and device for assessing cooking quality
EP3662293A4 (en) SAMPLE MEASUREMENT METHODS AND APPARATUS
EP3667327A4 (en) AUTOMATIC ANALYSIS DEVICE
IL277957A (en) E-beam facility
EP3371730A4 (en) AUTOMATED SAMPLE QUALITY ASSESSMENT
GB201819372D0 (en) Apparatus for analysing ions
EP3282698A4 (en) Method and apparatus for evaluating video quality
EP3608659A4 (en) QUALITY CONTROL PROCEDURE
GB201914091D0 (en) Test Apparatus
GB201818581D0 (en) Test apparatus
GB201809969D0 (en) Test apparatus
IL282440A (en) control device
GB201806504D0 (en) Sample holder
EP3488305C0 (de) Verfahren und vorrichtung zur ermittlung der bauteilqualität
FI3966646T3 (fi) Menetelmä laatuvirheiden analysoimiseksi
GB201900835D0 (en) Test apparatus
GB2575779B (en) Testing apparatus
EP3807614C0 (de) Mikrotom
GB201901164D0 (en) Test apparatus
EP3578951A4 (en) AUTOMATED DEVICE FOR SAMPLING PYROLYSIS